Mark Altmeyer – Biography

Last update: March 3, 2026

Executive profile

Mark was Chief Executive Officer at Arvelle Therapeutics, and President and Chief Commercial Officer at Axovant Sciences. Mark Altmeyer joined AM-Pharma in 2026.

Mark Altmeyer is currently

Create your alert
to follow the career of Mark Altmeyer.

Education

Mark Altmeyer has a Bachelor of Economics from Middlebury College in 1982 and a Master of Business Administration from Harvard Business School in 1988.

They have also studied at Middlebury College :

Find more alumni from Middlebury College


They have also studied at Harvard Business School :

Find more alumni from Harvard Business School

The colleagues of Mark Altmeyer

Company Colleagues
Industry Colleagues
  • In the Pharmaceuticals industry, Mark Altmeyer has 22,990 colleagues in 1,914 companies located in 68 countries. 10,828 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Mark Altmeyer.

Get in Touch

Here are a few tips for establishing great contacts.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.